psychoactive drug

向精神薬

WordNet

1. use recreational drugs (同)do drugs
2. administer a drug to; "They drugged the kidnapped tourist" (同)dose
3. a substance that is used as a medicine or narcotic
4. affecting the mind or mood or other mental processes; "psychoactive drugs" (同)psychotropic

PrepTutorEJDIC

1. 『薬』,薬品,薬剤 / 『麻薬』,麻酔剤 / 〈人〉‘に'薬(特に麻酔剤)を与える / 〈飲食物〉‘に'(麻酔薬・毒薬などの)薬を混ぜる

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/08/07 16:43:04」(JST)

wiki en

[Wiki en表示]

An assortment of psychoactive drugs

A psychoactive drug, psychopharmaceutical, or psychotropic is a chemical substance that crosses the blood–brain barrier and acts primarily upon the central nervous system where it affects brain function, resulting in alterations in perception, mood, consciousness, cognition, and behavior. These substances may be used recreationally, to purposefully alter one's consciousness, or as entheogens, for ritual, spiritual, and/or shamanic purposes, as a tool for studying or augmenting the mind. Many psychoactive drugs have therapeutic utility, e.g., as anesthetics, analgesics, or for the treatment of psychiatric disorders.

Psychoactive substances often bring about subjective changes in consciousness and mood that the user may find pleasant (e.g. euphoria) or advantageous (e.g. increased alertness) and are thus reinforcing. Thus, many psychoactive substances are abused, that is, used excessively, despite health risks or negative consequences. With sustained use of some substances, psychological and physical dependence ("addiction") may develop, making the cycle of abuse even more difficult to interrupt. Drug rehabilitation aims to break this cycle of dependency, through a combination of psychotherapy, support groups, maintenance and even other psychoactive substances. However, the reverse is also true in some cases, that certain experiences on drugs may be so unfriendly and uncomforting that the user may never want to try the substance again. This is especially true of the deliriants (e.g. Jimson weed) and powerful dissociatives (e.g. Salvia divinorum). Most purely psychedelic drugs are considered to be non-addictive (e.g. LSD, psilocybin, mescaline). "Psychedelic amphetamines" or empathogen-entactogens (such as MDA and MDMA) may produce an additional stimulant and/or euphoriant effect, and thus have an addiction potential.

In part because of this potential for abuse and dependency, the ethics of drug use are debated. Many governments worldwide place restrictions on drug production and sales in an attempt to decrease drug abuse. Ethical concerns have also been raised about over-use of these drugs clinically, and about their marketing by manufacturers.

History

Psychoactive drug use dates to prehistoric times. There is archaeological evidence of the use of psychoactive substances (mostly plants) dating back at least 10,000 years, and historical evidence of cultural use over the past 5,000 years. The chewing of coca leaves, for example, dates back over 8000 years ago in Peruvian society.

Medicinal use is one important facet of psychoactive drug usage. However, some have postulated that the urge to alter one's consciousness is as primary as the drive to satiate thirst, hunger or sexual desire. The long history of drug use and even children's desire for spinning, swinging, or sliding indicates that the drive to alter one's state of mind is universal.

One of the first people to articulate this point of view, set aside from a medicinal context, was American author Fitz Hugh Ludlow (1836–1870) in his book The Hasheesh Eater (1857): "...drugs are able to bring humans into the neighborhood of divine experience and can thus carry us up from our personal fate and the everyday circumstances of our life into a higher form of reality. It is, however, necessary to understand precisely what is meant by the use of drugs. We do not mean the purely physical craving...That of which we speak is something much higher, namely the knowledge of the possibility of the soul to enter into a lighter being, and to catch a glimpse of deeper insights and more magnificent visions of the beauty, truth, and the divine than we are normally able to spy through the cracks in our prison cell. But there are not many drugs which have the power of stilling such craving. The entire catalog, at least to the extent that research has thus far written it, may include only opium, hashish, and in rarer cases alcohol, which has enlightening effects only upon very particular characters."

This relationship is not limited to humans. A number of animals consume different psychoactive plants, animals, berries and even fermented fruit, becoming intoxicated, such as cats after consuming catnip. Traditional legends of sacred plants often contain references to animals that introduced humankind to their use. Biology suggests an evolutionary connection between psychoactive plants and animals, as to why these chemicals and their receptors exist within the nervous system.

During the 20th century, many governments across the world initially responded to the use of recreational drugs by banning them and making their use, supply, or trade a criminal offense. A notable example of this is the Prohibition era in the United States, where alcohol was made illegal for 13 years. However, many governments, government officials and persons in law enforcement have concluded that illicit drug use cannot be sufficiently stopped through criminalization. Organizations such as Law Enforcement Against Prohibition (LEAP) have come to such a conclusion believing "the existing drug policies have failed in their intended goals of addressing the problems of crime, drug abuse, addiction, juvenile drug use, stopping the flow of illegal drugs into this country and the internal sale and use of illegal drugs. By fighting a war on drugs the government has increased the problems of society and made them far worse. A system of regulation rather than prohibition is a less harmful, more ethical and a more effective public policy." In some countries, there has been a move toward harm reduction by health services, where the use of illicit drugs is neither condoned nor promoted, but services and support are provided to ensure users have adequate factual information readily available, and that the negative effects of their use be minimized. Such is the case of Portuguese drug policy of decriminalization, which achieved its primary goal of reducing the adverse health effects of drug abuse.

Uses

Psychoactive substances are used by humans for a number of different purposes to achieve a specific end. These uses vary widely between cultures. Some substances may have controlled or illegal uses while others may have shamanic purposes, and still others are used medicinally. Other examples would be social drinking or sleep aids. Caffeine is the world's most widely consumed psychoactive substance, but unlike many others, it is legal and unregulated in nearly all jurisdictions. In North America, 90% of adults consume caffeine daily.

Psychoactive drugs are divided into different groups according to their pharmacological effects. Commonly used psychoactive drugs and groups:

• Anxiolytics

Example: Benzodiazepine

• Euphoriants

Example: MDMA (Ecstasy), MDA, 6-APB, Indopan

• Stimulants ("uppers"). This category comprises substances that wake one up, stimulate the mind, and may even cause euphoria, but do not affect perception.

Examples: amphetamine, caffeine, cocaine, nicotine

• Depressants ("downers"), including sedatives, hypnotics, and narcotics. This category includes all of the calmative, sleep-inducing, anxiety-reducing, anesthetizing substances, which sometimes induce perceptual changes, such as dream images, and also often evoke feelings of euphoria.

Examples: alcoholic beverages (ethanol), opioids, barbiturates, benzodiazepines.

• Hallucinogens, including psychedelics, dissociatives and deliriants. This category encompasses all those substances that produce distinct alterations in perception, sensation of space and time, and emotional states.

Examples: psilocybin, LSD, Salvia divinorum and nitrous oxide.

Marijuana is an example of a psychoactive drug that combines properties of each of these groups.

Use in practice: The theory of dose, set, and setting

The theory of dosage, set, and setting is a useful model in dealing with the effects of psychoactive substances, especially in a controlled therapeutic setting as well as in recreational use. Dr. Timothy Leary, based on his own experiences and systematic observations on psychedelics, developed this theory along with his colleagues Ralph Metzner, and Richard Alpert (Ram Dass) in the 1960s.

Dosage

The first factor, dosage, has been a truism since ancient times, or at least since Paracelsus who said, "Dose makes the poison." Some compounds are beneficial or pleasurable when consumed in small amounts, but harmful, deadly, or evoke discomfort in higher doses.

Set

The set is the internal attitudes and constitution of the person, including their expectations, wishes, and fears. This factor is especially important for the hallucinogens, which have the ability to make conscious experiences out of the unconscious. In traditional cultures, set is shaped primarily by the worldview that all the members of the culture share.

Setting

The third aspect is setting, which pertains to the surroundings, the place, and the time in which the experiences transpire.

This theory clearly states that the effects are equally the result of chemical, pharmacological, psychological, and physical influences. The model that Timothy Leary proposed applied to the psychedelics, although it also applies to other psychoactives.

Anesthesia

Main article: Anesthesia

General anesthetics are a class of psychoactive drug used on patients to block pain and other sensations. Most anesthetics induce unconsciousness, which allows patients to undergo medical procedures like surgery without physical pain or emotional trauma. To induce unconsciousness, anesthetics affect the GABA and NMDA systems. For example, halothane is a GABA agonist, and ketamine is an NMDA receptor antagonist.

Pain management

Main article: Analgesics

Psychoactive drugs are often prescribed to manage pain. The subjective experience of pain is primarily regulated by endogenous opioid peptides. Thus, pain can often be managed using psychoactives that operate on this neurotransmitter system, also known as opioid receptor agonists. This class of drugs can be highly addictive, and includes opiate narcotics, like morphine and codeine. NSAIDs, such as aspirin and ibuprofen, are also analgesics. These agents also reduce eicosanoid-mediated inflammation by inhibiting the enzyme cyclooxygenase.

Psychiatric medication

Main article: Psychiatric medications

Zoloft (sertraline) is an SSRI antidepressant.

Psychiatric medications are psychoactive drugs prescribed for the management of mental and emotional disorders. There are six major classes of psychiatric medications:

• Antidepressants, treat disparate disorders such as clinical depression, dysthymia, anxiety, eating disorders and borderline personality disorder.
• Stimulants, which are used to treat disorders such as attention deficit disorder and narcolepsy and to suppress the appetite.
• Antipsychotics, which are used to treat psychotic symptoms, such as those associated with schizophrenia or severe mania.
• Mood stabilizers, which are used to treat bipolar disorder and schizoaffective disorder.
• Anxiolytics, which are used to treat anxiety disorders.
• Depressants, which are used as hypnotics, sedatives, and anesthetics, depending upon dosage.

In addition, several psychoactive substances are currently employed to treat dependence on other substances. These include acamprosate or naltrexone in the treatment of alcoholism, or methadone or buprenorphine maintenance therapy in the case of opioid dependency.^{[citation needed]}

Exposure to psychoactive drugs can cause changes to the brain that counteract their effects, making their effects temporary and leading to physical dependence (see Effects, below).

Recreational use

Main article: Recreational drug use

Many psychoactive substances are used for their mood and perception altering effects, including those with accepted uses in medicine and psychiatry. Examples include caffeine, alcohol, cocaine, LSD, and cannabis. Classes of drugs frequently used recreationally include:

• Stimulants, which activate the central nervous system. These are used recreationally for their euphoric effects.
• Hallucinogens (psychedelics, dissociatives and deliriants), which induce perceptual and cognitive distortions.
• Hypnotics, which depress the central nervous system. These are used recreationally because of their euphoric effects.
• Opioid analgesics, which also depress the central nervous system. These are used recreationally because of their euphoric effects.
• Inhalants, in the forms of gas aerosols, or solvents, which are inhaled as a vapor because of their stupefying effects. Many inhalants also fall into the above categories (such as nitrous oxide which is also an analgesic).

In some modern and ancient cultures, drug usage is seen as a status symbol. Recreational drugs are seen as status symbols in settings such as at nightclubs and parties. For example, in ancient Egypt, gods were commonly pictured holding hallucinogenic plants.

Because there is controversy about regulation of recreational drugs, there is an ongoing debate about drug prohibition. Critics of prohibition believe that regulation of recreational drug use is a violation of personal autonomy and freedom. In the United States, critics have noted that prohibition or regulation of recreational and spiritual drug use might be unconstitutional.

Ritual and spiritual use

Timothy Leary was a leading proponent of spiritual hallucinogen use.

Main article: Entheogens

Certain psychoactives, particularly hallucinogens, have been used for religious purposes since prehistoric times. Native Americans have used peyote cacti containing mescaline for religious ceremonies for as long as 5700 years. The muscimol-containing Amanita muscaria mushroom was used for ritual purposes throughout prehistoric Europe. Various other hallucinogens, including jimsonweed, psilocybin mushrooms, and cannabis, have been used in religious ceremonies for millennia.

The use of entheogens for religious purposes resurfaced in the West during the counterculture movements of the 1960s and 70s. Under the leadership of Timothy Leary, new religious movements began to use LSD and other hallucinogens as sacraments. In the United States, the use of peyote for ritual purposes is protected only for members of the Native American Church, which is allowed to cultivate and distribute peyote. However, the genuine religious use of Peyote, regardless of one's personal ancestry, is protected in Colorado, Arizona, New Mexico, Nevada, and Oregon.

Military

Main article: Psychochemical weapons

Psychoactive drugs have been used in military applications as non-lethal weapons. In World War II, between 1939 and 1945, 60 million amphetamine pills were made for use by soldiers.^{[citation needed]} Brown-brown, a form of cocaine adulterated with gunpowder, has been used in the Sierra Leone Civil War by child soldiers.^{[citation needed]}

Both military and civilian American intelligence officials are known to have used psychoactive drugs while interrogating captives apprehended in its War on Terror. In July 2012, Jason Leopold and Jeffrey Kaye, psychologists and human rights workers, had a Freedom of Information Act request fulfilled that confirmed that the use of psychoactive drugs during interrogation was a long-standing practice. Captives and former captives had been reporting medical staff collaborating with interrogators to drug captives with powerful psychoactive drugs prior to interrogation since the very first captives' release. In May 2003, recently released Pakistani captive Sha Mohammed Alikhel described the routine use of psychoactive drugs. He said that Jihan Wali, a captive kept in a nearby cell, was rendered catatonic through the use of these drugs.

Administration

For a substance to be psychoactive, it must cross the blood–brain barrier so it can affect neurochemical function. Psychoactive drugs are administered in several different ways. In medicine, most psychiatric drugs, such as fluoxetine, quetiapine, and lorazepam are ingested orally in tablet or capsule form. However, certain medical psychoactives are administered via inhalation, injection, or rectal suppository/enema. Recreational drugs can be administered in several additional ways that are not common in medicine. Certain drugs, such as alcohol and caffeine, are ingested in beverage form; nicotine and cannabis are often smoked; peyote and psilocybin mushrooms are ingested in botanical form or dried; and certain crystalline drugs such as cocaine and methamphetamines are often insufflated (inhaled or "snorted"). The efficiency of each method of administration varies from drug to drug.

Effects

Illustration of the major elements of neurotransmission. Depending on its method of action, a psychoactive substance may block the receptors on the post-synaptic neuron (dendrite), or block reuptake or affect neurotransmitter synthesis in the pre-synaptic neuron (axon).

Main article: Neuropsychopharmacology

Psychoactive drugs operate by temporarily affecting a person's neurochemistry, which in turn causes changes in a person's mood, cognition, perception and behavior. There are many ways in which psychoactive drugs can affect the brain. Each drug has a specific action on one or more neurotransmitter or neuroreceptor in the brain.

Drugs that increase activity in particular neurotransmitter systems are called agonists. They act by increasing the synthesis of one or more neurotransmitters, by reducing its reuptake from the synapses, or by mimicking the action by binding directly to the postsynaptic receptor. Drugs that reduce neurotransmitter activity are called antagonists, and operate by interfering with synthesis or blocking postsynaptic receptors so that neurotransmitters cannot bind to them.

Exposure to a psychoactive substance can cause changes in the structure and functioning of neurons, as the nervous system tries to re-establish the homeostasis disrupted by the presence of the drug (see also, Neuroplasticity). Exposure to antagonists for a particular neurotransmitter increases the number of receptors for that neurotransmitter, and the receptors themselves become more sensitive. This is called sensitization. Conversely, overstimulation of receptors for a particular neurotransmitter causes a decrease in both number and sensitivity of these receptors, a process called desensitization or tolerance. Sensitization and desensitization are more likely to occur with long-term exposure, although they may occur after only a single exposure. These processes are thought to underlie dependence and addiction. Physical dependence on antidepressants or anxiolytics may result in worse depression or anxiety, respectively, as withdrawal symptoms. Unfortunately, because clinical depression (also called major depressive disorder) is often referred to simply as depression, antidepressants are often requested by and prescribed for patients who are depressed, but not clinically depressed.

Affected neurotransmitter systems

The following is a brief table of notable drugs and their primary neurotransmitter, receptor or method of action. It should be noted that many drugs act on more than one transmitter or receptor in the brain.

Neurotransmitter/receptor	Classification	Examples
Acetylcholine	Cholinergics (acetylcholine receptor agonists)	arecoline, nicotine, piracetam
	Muscarinic antagonists (acetylcholine receptor antagonists)	scopolamine, benzatropine, dimenhydrinate, diphenhydramine, atropine, quetiapine, olanzapine, most tricyclics
	Nicotinic antagonists (acetylcholine receptor antagonists)	memantine, bupropion
Adenosine	Adenosine receptor antagonists	caffeine, theobromine, theophylline
Dopamine	Dopamine reuptake inhibitors (DRIs)	cocaine, amphetamine, bupropion, methylphenidate
	Dopamine releasers	amphetamine, agomelatine
	Dopamine receptor agonists	pramipexole, Ropinirole, L-DOPA (prodrug), memantine (also see NMDA, below)
	Dopamine receptor antagonists	haloperidol, droperidol, many antipsychotics (e.g., risperidone, olanzapine, quetiapine)
	Dopamine receptor partial agonists	aripiprazole
GABA	GABA reuptake inhibitors	tiagabine, vigabatrin
	GABA receptor agonists	ethanol, barbiturates, diazepam, clonazepam, lorazepam, temazepam, alprazolam and other benzodiazepines, zolpidem, eszopiclone, zaleplon and other nonbenzodiazepines, muscimol
	GABA receptor antagonists	thujone, bicuculline
Norepinephrine	Norepinephrine reuptake inhibitors	most non-SSRI antidepressants such as amoxapine, atomoxetine, bupropion, venlafaxine, quetiapine, the tricyclics, methylphenidate, SNRIs such as duloxetine, venlafaxine.
	Norepinephrine releasers	ephedrine, mianserin, mirtazapine, PPA, pseudoephedrine
	Norepinephrine receptor agonists	clonidine, guanfacine, phenylephrine
	Norepinephrine receptor antagonists	carvedilol, metoprolol, mianserin, prazosin, propranolol, trazodone, yohimbine, olanzapine
Serotonin	Serotonin receptor agonists	LSD, psilocybin, mescaline, DMT
	Serotonin reuptake inhibitors	most antidepressants including tricyclics such as imipramine, SSRIs such as fluoxetine, sertraline and citalopram, and SNRIs such as duloxetine and venlafaxine
	Serotonin releasers	fenfluramine, MDMA (ecstasy), mephedrone, mirtazapine, tramadol
	Serotonin receptor antagonists	ritanserin, mirtazapine, mianserin, trazodone, cyproheptadine, memantine, atypical antipsychotics (e.g., risperidone, olanzapine, quetiapine)
AMPA receptor	AMPA receptor positive allosteric modulators	aniracetam, CX717, piracetam
	AMPA receptor antagonists	kynurenic acid, NBQX, topiramate
Cannabinoid receptor	Cannabinoid receptor agonists	THC, cannabidiol, cannabinol
	Cannabinoid receptor inverse agonists	Rimonabant
	Anandamide reuptake inhibitors	URB597, LY-2183240. PF-04457845
Melanocortin receptor	Melanocortin receptor agonists	bremelanotide
NMDA receptor	NMDA receptor antagonists	ethanol, ketamine, PCP, DXM, Nitrous Oxide, glutamate, memantine (used for moderate to severe Alzheimers)
GHB receptor	GHB receptor agonists	GHB, amisulpiride, T-HCA
Sigma receptor	Sigma-1 receptor agonists	cocaine, DMT, DXM, fluvoxamine, ibogaine, opipramol, PCP
Opioid receptor	μ-opioid receptor agonists	morphine, heroin, oxycodone, codeine
	μ-opioid receptor partial agonists	buprenorphine
	μ-opioid receptor inverse agonists	naloxone
	μ-opioid receptor antagonists	naltrexone
	κ-opioid receptor agonists	salvinorin A, butorphanol, nalbuphine, pentazocine, ibogaine
	κ-opioid receptor antagonists	buprenorphine
Histamine receptor	H1 histamine receptor antagonists	diphenhydramine, doxylamine, mirtazapine, mianserin, quetiapine, olanzapine, meclozine, dimenhydrinate, most tricyclics
Monoamine oxidase	Monoamine oxidase inhibitors (MAOIs)	phenelzine, iproniazid, tranylcypromine
	bind to MAO protein transporter	amphetamine, methamphetamine
Melatonin receptor	Melatonin receptor agonists	ramelteon
Imidazoline receptor	Imidazoline receptor agonists	apraclonidine, clonidine, moxonidine, rilmenidine
Orexin receptor	Orexin receptor agonists	modafinil
	Orexin receptor antagonists	SB-334,867, SB-408,124, TCS-OX2-29

Addiction

Main article: Substance use disorder

Comparison of physical harm and dependence of various drugs as estimated by The Lancet.

Psychoactive drugs are often associated with addiction. Addiction can be divided into two types: psychological addiction, by which a user feels compelled to use a drug despite negative physical or societal consequence, and physical dependence, by which a user must use a drug to avoid physically uncomfortable or even medically harmful withdrawal symptoms. Not all drugs are physically addictive, but any activity that stimulates the brain's dopaminergic reward system — typically, any pleasurable activity — can lead to psychological addiction. Drugs that are most likely to cause addiction are drugs that directly stimulate the dopaminergic system, like cocaine and amphetamines. Drugs that only indirectly stimulate the dopaminergic system, such as psychedelics, are not as likely to be addictive.^{[citation needed]}

Many professionals, self-help groups, and businesses specialize in drug rehabilitation, with varying degrees of success, and many parents attempt to influence the actions and choices of their children regarding psychoactives.

Common forms of rehabilitation include psychotherapy, support groups and pharmacotherapy, which uses psychoactive substances to reduce cravings and physiological withdrawal symptoms while a user is going through detox. Methadone, itself an opioid and a psychoactive substance, is a common treatment for heroin addiction, as is another opioid, buprenorphine. Recent research on addiction has shown some promise in using psychedelics such as ibogaine to treat and even cure addictions, although this has yet to become a widely accepted practice.

Legality

Historical image of legal heroin bottle

Main article: Prohibition of drugs

The legality of psychoactive drugs has been controversial through most of recent history; the Second Opium War and Prohibition are two historical examples of legal controversy surrounding psychoactive drugs. However, in recent years, the most influential document regarding the legality of psychoactive drugs is the Single Convention on Narcotic Drugs, an international treaty signed in 1961 as an Act of the United Nations. Signed by 73 nations including the United States, the USSR, India, and the United Kingdom, the Single Convention on Narcotic Drugs established Schedules for the legality of each drug and laid out an international agreement to fight addiction to recreational drugs by combatting the sale, trafficking, and use of scheduled drugs. All countries that signed the treaty passed laws to implement these rules within their borders. However, some countries that signed the Single Convention on Narcotic Drugs, such as the Netherlands, are more lenient with their enforcement of these laws.

In the United States, the Food and Drug Administration (FDA) has authority over all drugs, including psychoactive drugs. The FDA regulates which psychoactive drugs are over the counter and which are only available with a prescription. However, certain psychoactive drugs, like alcohol, tobacco, and drugs listed in the Single Convention on Narcotic Drugs are subject to criminal laws. The Controlled Substances Act of 1970 regulates the recreational drugs outlined in the Single Convention on Narcotic Drugs. Alcohol is regulated by state governments, but the federal National Minimum Drinking Age Act penalizes states for not following a national drinking age. Tobacco is also regulated by all fifty state governments. Most people accept such restrictions and prohibitions of certain drugs, especially the "hard" drugs, which are illegal in most countries.

At the beginning of the 21st century, legally prescribed illegal psychoactive drugs used for legitimate purposes have been targeted by the US Justice System.

In the medical context, psychoactive drugs as a treatment for illness is widespread and generally accepted. Little controversy exists concerning over the counter psychoactive medications in antiemetics and antitussives. Psychoactive drugs are commonly prescribed to patients with psychiatric disorders. However, certain critics believe that certain prescription psychoactives, such as antidepressants and stimulants, are overprescribed and threaten patients' judgement and autonomy.

See also

• Contact high
• Counterculture of the 1960s
• Demand reduction           
• Designer drug
• Drug
• Drug addiction
• Drug rehabilitation
• Hard and soft drugs
• Neuropsychopharmacology           
• Poly drug use
• Project MKULTRA
• Psychedelic plants
• Recreational drug use
• Responsible drug use
• Self-medication
• Zombie dust

References

Notes

External links

• Neuroscience of Psychoactive Substance Use and Dependence by the WHO

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 薬物アレルギー患者へのアプローチ an approach to the patient with drug allergy
• 2. 抗マラリア剤：概要 antimalarial drugs an overview
• 3. 成人における薬物中毒への一般的アプローチ general approach to drug poisoning in adults
• 4. リウマチ性疾患における免疫抑制剤および疾患修飾剤の使用の概要 overview of the use of immunosuppressive and disease modifying drugs in the rheumatic diseases
• 5. 処方剤の誤用：疫学、予防、同定、およびマネージメント prescription drug misuse epidemiology prevention identification and management

English Journal

• Survey on alcohol and medicine abuse among adolescents at four schools in Greater Buenos Aires.

• Cabrerizo S1, Varela S2, Lutz MI3.
• Archivos argentinos de pediatria.Arch Argent Pediatr.2014 Dec;112(6):504-510.
• Introduction.The use of alcohol and prescription drugs acquired without a prescription among adolescents has become an increasing problem at departments of toxicology. The "jarra loca" is a mix of alcoholic beverages and medicines abused by teens. In the past years, in addition to psychotropic drugs
• PMID 25362908

• Wake-promoting pharmacotherapy for psychiatric disorders.

• Dell'Osso B1, Dobrea C, Cremaschi L, Arici C, Altamura AC.
• Current psychiatry reports.Curr Psychiatry Rep.2014 Dec;16(12):524. doi: 10.1007/s11920-014-0524-2.
• Medications promoting wakefulness are currently used in psychopharmacology in different contexts and with different objectives. In particular, they may be used for the treatment of syndromes that primarily show significant impairment in alertness/wakefulness (e.g., excessive sleepiness and other sle
• PMID 25312027

• Evaluation of bias in predicted and measured propofol concentrations during target-controlled infusions in obese Japanese patients: An open-label comparative study.

• Tachibana N1, Niiyama Y, Yamakage M.
• European journal of anaesthesiology.Eur J Anaesthesiol.2014 Dec;31(12):701-7. doi: 10.1097/EJA.0000000000000154.
• BACKGROUND: Target-controlled infusions (TCIs) of propofol are commonly used for general anaesthesia. The Marsh model pharmacokinetic parameter set incorporated in TCI devices for propofol could increase bias when used in obese patients.OBJECTIVE: The purpose of this study was to assess the optimal
• PMID 25192266

Japanese Journal

• 向精神薬大量内服による横紋筋融解症をともなった Coma Blister の1 例

• 西日本皮膚科 78(2), 140-144, 2016
• NAID 130005163125

• Regulation of Human Kv1.4 Channel Activity by the Antidepressant Metergoline

• Biological and Pharmaceutical Bulletin 39(6), 1069-1072, 2016
• NAID 130005155130

• うつ病患者の全身麻酔導入後に起こった異常低血圧の1症例

• 麻酔 64(11), 1198-1202, 2015-11
• NAID 40020641603

Related Links

• Psychoactive drug - ScienceDaily: Your source for the latest ...

A psychoactive drug or psychotropic substance is a chemical substance that acts primarily upon the central nervous system where it alters brain function, resulting in temporary changes in perception, mood, consciousness and ...

• Psychoactive drug

Psychoactive drug

Related Pictures

---

★リンクテーブル★

リンク元	「精神刺激薬」「向精神薬」「精神活性剤」
関連記事	「psychoactive」「drug」

「精神刺激薬」

　　[★]

英

psychostimulant

同？

精神賦活薬 psychoactive drug psychic energizer

中枢神経興奮薬　←使いわけは？、精神賦活薬

関

向精神薬

[show details]

精神賦活薬 : 約 103,000 件
精神刺激薬 : 約 110,000 件
精神賦活薬 psychoactive : 14 件
精神刺激薬 psychoactive : 32 件

概念

• 中枢機能を亢進して精神を高揚させる薬物

精神刺激薬

• カフェイン

• アンフェタミン
• メタンフェタミン

• メチルフェニデート：ナルコレプシー
• ペモリン：ナルコレプシー

「向精神薬」

　　[★]

英

psychotropic drug, psychotropic drugs, psychotropic agent, psychoactive drug, psychotropic, psychotropics

関

精神疾患

• 中枢神経系に作用して精神機能に影響を及ぼす薬物の総称

向精神薬に含まれる薬物

• 1. 抗精神病薬 antipsychotic drug <-メジャートランキライザー
• 2. 抗不安薬 antianxiety
• 3. 抗躁薬 antimanic
• 4. 抗うつ薬 antidepressant

-

• 5. 精神刺激薬 psychostimulants

「精神活性剤」

　　[★]

英

psychoactive drug

関

向精神薬、精神賦活薬

「psychoactive」

　　[★]

• adj.

• 精神賦活性の、向精神の

関

psychotropic

　

「drug」

　　[★]

同

drugs